Pyxisoncology

Clinical stage immunotherapy company

This company develops next-generation antibody-drug conjugates to treat patients with solid tumor malignancies.

ALX Oncology

This clinical-stage biopharmaceutical company develops novel therapies to treat cancer patients by expanding the possibilities of immuno-oncology and antibody-drug conjugates.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Pionyr Immunotherapeutics

This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.

Mersana Therapeutics

This company develops antibody-drug conjugates to treat various cancers for healthcare providers and patients within the oncology sector.

Heidelberg Pharma AG

This biopharmaceutical company develops antibody-drug conjugates for oncology patients using proprietary toxin technology to target and eliminate cancer cells.